UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 22, 2012
NBTY, Inc.
(Exact Name of Registrant as Specified in Charter)
333-172973
(Commission File Number)
|
DELAWARE |
|
11-2228617 |
|
(State or Other Jurisdiction |
|
(I.R.S. Employer |
|
of Incorporation) |
|
Identification No.) |
|
2100 Smithtown Avenue |
|
|
|
Ronkonkoma, New York |
|
11779 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
(631) 567-9500
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 22, 2012, NBTY, Inc. (the “Company”) announced that Irene Fisher, its Senior Vice President and General Counsel, will leave the Company by mutual consent in order to pursue other opportunities. Ms. Fisher has agreed to remain at the Company until May 18, 2012 to facilitate an orderly transition.
ITEM 8.01 Other Events.
On March 22, 2012, the Company announced the hiring of Christopher Brennan as the Company’s new Senior Vice President, General Counsel. Mr. Brennan joins the Company from PharmaNet Development Group, Inc., where he held the position of General Counsel.